Infliximab <i>vs</i> interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial
- DOI
- 10.1093/rheumatology/keae585
- Published
- 2024-10-21
- Container
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keae585,
title = {Infliximab <i>vs</i> interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial},
author = {Robert J Moots and Farida Fortune and Richard Jackson and Tony Thornburn and Ann Morgan and Daniel F Carr and Philip I Murray and Graham R Wallace and Deva Situnayake},
year = {2024},
journal = {Rheumatology},
doi = {10.1093/rheumatology/keae585},
url = {https://doi.org/10.1093/rheumatology/keae585}
}RIS
TY - JOUR TI - Infliximab <i>vs</i> interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial AU - Robert J Moots AU - Farida Fortune AU - Richard Jackson AU - Tony Thornburn AU - Ann Morgan AU - Daniel F Carr AU - Philip I Murray AU - Graham R Wallace AU - Deva Situnayake PY - 2024 JO - Rheumatology DO - 10.1093/rheumatology/keae585 UR - https://doi.org/10.1093/rheumatology/keae585 ER -
APA
Moots, R. J., Fortune, F., Jackson, R., Thornburn, T., Morgan, A., Carr, D. F., Murray, P. I., Wallace, G. R., & Situnayake, D. (2024). Infliximab <i>vs</i> interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial. Rheumatology. https://doi.org/10.1093/rheumatology/keae585
Source records
- crossref · retrieved 2026-09-26T12:39:26.298Z